Paragon Biosciences Launches a Facility for the Advancement of QuantX Medical Imaging AI System Diagnosing Breast Cancer

 Paragon Biosciences Launches a Facility for the Advancement of QuantX Medical Imaging AI System Diagnosing Breast Cancer

Paragon Biosciences Launches a Facility for the Advancement of QuantX Medical Imaging AI System Diagnosing Breast Cancer

Shots:

  • Paragon’s facility, Qlarity Imaging will lead the expansion of diagnostic applications of QuantX, with the additional ability of image modalities and medical conditions, improving patient care by advancing breast cancer diagnosis system in radiology
  • The clinical study results assessing QuantX demonstrated a 39% reduction in missed breast cancers without a reduction in specificity and 20% overall diagnostic improvement
  • QuantX is a computer-aided breast cancer diagnosis software for radiology and is the first FDA cleared AI breast cancer diagnostic tool

Click here to read full press release/ article | Ref: Paragon Biosciences | Image:Paragon Biosciences

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post